Team

Patrick Chu, President

Mr. Chu is one of the co-founders of Edenbridge Pharmaceuticals and currently serves as President. Mr. Chu was previously the Director of Business Development and Associate General Counsel for DAVA Pharmaceuticals. Prior to joining DAVA, Mr. Chu worked at Wyeth and was also previously an associate at the law firm of Skadden Arps. Mr. Chu holds a law degree from Harvard Law School.

Marc Padre, Chief Finance Officer

Mr. Padre has held finance positions in large multi-national publicly traded companies as well as small privately held pharmaceutical companies. Prior to joining Edenbridge, Mr. Padre served as Vice President, Corporate Controller for Vertice Pharmaceuticals and prior to that Mr. Padre served as the US Controller for Bausch Health Companies during a period of seventeen stock acquisitions and growth in market capital from $2B to $80B. Mr. Padre also served as an adjunct professor in accounting and information systems at The College of New Jersey. Mr. Padre earned Summa Cum Laude honors while earning a B.S. degree in Accounting from Arizona State University and was formerly licensed as a CPA in California.

Mike White, Senior Vice President, Sales & Marketing

Mr. White is responsible for the development and execution of Edenbridge Pharmaceuticals' generic sales & marketing strategy and leading all trade relations, product launches, sales infrastructure, customer service, and sales logistics related to Edenbridge's generic product portfolio. Prior to joining Edenbridge, Mr. White held various sales & marketing roles at Nostrum Laboratories, Actavis, Rising Pharmaceuticals, and PACK Pharmaceuticals. Mr. White holds a B.A. in Political Science from Purdue University.

Daniel G. Worley Jr., PharmD, Esq., Senior Vice President, Business Development & General Counsel

Dr. Worley is a patent attorney and registered pharmacist who is responsible for all business development and legal operations at Edenbridge Pharmaceuticals. Prior to joining Edenbridge, Dr. Worley was an associate at Haug Partners LLP (f/k/a Frommer Lawrence & Haug LLP) where he specialized in patent and FDA regulatory law. Dr. Worley holds a PharmD, magna cum laude, from Rutgers University and a JD, cum laude, from Seton Hall University.

Debashis Das, Ph.D., Vice President, R&D

Dr. Das is responsible for all product development & technical transfer activities at Edenbridge Pharmaceuticals. Prior to joining Edenbridge, Dr. Das held senior roles at Endo and Par Pharmaceuticals. Dr. Das possesses over 20 years of experience in providing analytical support to development of IND, NDA, and ANDA drug products. Dr. Das obtained his Ph.D. degree in Chemistry from Northern Illinois University.

Jason Nowack, Vice President, Quality Assurance

Mr. Nowack is responsible for all internal quality systems, oversight of external quality activities and DSCSA compliance for Edenbridge Pharmaceuticals. Mr. Nowack has over 21 years of experience in the pharmaceutical industry with 15 years in quality assurance. Prior to joining Edenbridge, Mr. Nowack was most recently the site quality head for Aprecia Pharmaceuticals. Mr. Nowack holds a B.S. degree in biotechnology from Rutgers University.

David McCullough, Vice President, Market Access

Mr. McCullough is responsible for the market access function and creating pathways to coverage for Edenbridge’s branded portfolio. Prior to joining Edenbridge, Mr. McCullough held various market access roles at Mirum Pharmaceuticals, Avexis/Novartis, Spark Therapeutics, Shire, and Medimmune. Mr. McCullough holds a B.A. in Speech and Public Relations from McNeese State University and a B.S in Theology from St Louis Christian College.

Scott Barry, Vice President, Finance

Mr. Barry brings to Edenbridge twenty years of financial experience, with many of those years spent within the pharmaceutical industry. Most recently, Mr. Barry served as Senior Finance Director for Bausch & Lomb and during his twelve years with Bausch & Lomb Mr. Barry held roles with increasing responsibilities and a focus on FP&A, driving performance, and increasing profitability. Throughout his career, Mr. Barry has worked across multiple industries, including pharmaceuticals, consumer products, manufacturing, and healthcare services. Mr. Barry holds a B.S. degree in Finance from Bryant University and an MBA in Strategic Business and Management from Rutgers University.